GSK will invest more than $800 million to expand its Upper Merion, Pennsylvania site into ​a new bio

SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery, the AI company building a computer-aided design suit

For the first time, Viola Davis shares her experience with shingles Viola encourages adults 50 years

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding

Analysts review high-yield healthcare stocks CVS, Medtronic and GSK, offering dividend yields of 3.0

GSK is accelerating its strategic transformation under new CEO Luke Miels, emphasizing M&A, pipeline

GSK (NYSE: GSK - Get Free Report) and Eyepoint Pharmaceuticals (NASDAQ: EYPT - Get Free Report) are

Candidate selected by GSK utilizes Wave's best-in-class SpiNA design siRNA and triggers a milestone

GSK and Sanofi offer distinct growth drivers, but stronger earnings estimates, Dupixent momentum and

Investment bank Jefferies has kept its ‘buy' rating and 2,500p target on GSK PLC (LSE:GSK, NYSE:GSK)

MRK and Daiichi withdraw an FDA filing for ifinatamab deruxtecan after data falls short, while late-

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage pharmac

GSK (NYSE: GSK) Chief Financial Officer Julie Brown outlined the company's growth strategy, launch p

GSK plc (GSK) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthc

GSK NYSE: GSK is advancing a respiratory and immunology pipeline centered on longer-acting biologics

GSK plc (GSK) Presents at Bank of America Global Healthcare Conference 2026 Transcript

GSK NYSE: GSK Chief Financial Officer Julie Brown outlined the company's growth strategy, launch pri

GSK NYSE: GSK is pursuing a focused oncology expansion built around hematologic malignancies, gyneco

GSK plc (GSK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

GSK's $750M Chimagen deal adds a trispecific TCE to its multiple myeloma portfolio, targeting two tu

GSK said on Tuesday it had agreed a deal worth up to $750 million ​to buy a trispecific T cell-engag

GSK shares jump over 4% on strong survival data for SCLC drug Ris-Rez and a 94% response rate for Ji

94% objective response rate at 15.2 months follow-up90% of patients were progression free at 12 mont

Analyst ratings and news for high-yield healthcare stocks Medtronic (3.06%), Smith & Nephew (2.7

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Haleon gains US market share at Walmart and Target by securing eye-level shelf placement with aggres

HUTCHMED stock jumps on a $1.3B GSK deal for its cancer drug HMPL-A830. Learn the financial terms an

GSK moves its dual-target mRNA seasonal flu vaccine to Phase 3 trials following strong Phase 2 data

Two unvaccinated Pennsylvania residents died of measles, the state’s first deaths in 35 years, as tr

Oz says the MMR vaccine is “not a lethal vaccine” after Trump warned the combined shot could be “qui

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

During market turbulence, investors turn to dividend-yielding stocks. Benzinga provides analyst rati

President Donald Trump signed an order Monday limiting core childhood vaccine recommendations to 11

https://youtu.be/H_RititNE8U

The Trump administration is reportedly considering an executive order on vaccines and autism as earl

https://www.gsk.com/en-gb/media/press-releases/cabenuva-demonstrates-superiority-to-daily-oral-thera

GSK beats Q2 revenue and earnings estimates, launches a $2.52B cost-savings program, and updates its

U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting bet

In times of market turbulence, dividend-yielding stocks are popular for investors. Check out analyst

GSK (NYSE:GSK) affirms FY2026 Adj EPS guidance from $4.90-$5.00 to $4.90-$5.00 vs $4.79 analyst esti

GSK (NYSE:GSK) reported quarterly earnings of $1.35 per share which beat the analyst consensus estim

Results add to a growing body of positive late-stage evidence for Ris-Rez, including recent pivotal

GSK Canada today announced the approval of Shingrix (GSK's Recombinant Zoster Vaccine or RZV) in

GSK wins early FDA approval for Jideytro, a targeted treatment for adults with advanced ROS1-positiv

GSK plc (LSE/NYSE:GSK) today announced the US Food and Drug Administration (FDA) has approved Jideyt

Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.

GSK stops development of chronic cough drug camlipixant after mixed Phase 3 results; continue testin

Investors turn to dividend-yielding stocks during market turbulence. Benzinga's Analyst Stock Ra

GSK Jemperli shows sustained complete responses in dMMR/MSI-H rectal cancer, potentially eliminating

GSK-backed Ris-Rez posts positive Phase 3 survival data in small-cell lung cancer as the company mov